Beini Cen

639 total citations
22 papers, 301 citations indexed

About

Beini Cen is a scholar working on Molecular Biology, Hepatology and Epidemiology. According to data from OpenAlex, Beini Cen has authored 22 papers receiving a total of 301 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Hepatology and 6 papers in Epidemiology. Recurrent topics in Beini Cen's work include Liver Disease Diagnosis and Treatment (6 papers), Cancer Mechanisms and Therapy (5 papers) and Hepatocellular Carcinoma Treatment and Prognosis (4 papers). Beini Cen is often cited by papers focused on Liver Disease Diagnosis and Treatment (6 papers), Cancer Mechanisms and Therapy (5 papers) and Hepatocellular Carcinoma Treatment and Prognosis (4 papers). Beini Cen collaborates with scholars based in China, Madagascar and United States. Beini Cen's co-authors include Shusen Zheng, Di Lu, Xiao Xu, Hangxiang Wang, Haiyang Xie, Xuyong Wei, Lulu Ren, Jianqin Wan, Yuchen Wang and Jianyong Zhuo and has published in prestigious journals such as Nano Letters, Biomaterials and Hepatology.

In The Last Decade

Beini Cen

21 papers receiving 301 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Beini Cen China 11 104 75 75 59 53 22 301
Runzhou Zhuang China 12 200 1.9× 55 0.7× 71 0.9× 100 1.7× 38 0.7× 21 393
Jingyuan Wang China 10 112 1.1× 39 0.5× 75 1.0× 20 0.3× 67 1.3× 15 331
Man Shu China 11 101 1.0× 145 1.9× 60 0.8× 86 1.5× 99 1.9× 25 418
Xiuling Lv China 12 146 1.4× 49 0.7× 123 1.6× 90 1.5× 38 0.7× 14 387
Amin Li China 15 233 2.2× 88 1.2× 79 1.1× 80 1.4× 84 1.6× 25 428
Shuguang Ju China 12 79 0.8× 79 1.1× 189 2.5× 33 0.6× 21 0.4× 39 368
Gianmarco Villano Italy 13 187 1.8× 49 0.7× 99 1.3× 115 1.9× 29 0.5× 28 426
Changli Peng China 6 66 0.6× 107 1.4× 70 0.9× 41 0.7× 16 0.3× 8 324

Countries citing papers authored by Beini Cen

Since Specialization
Citations

This map shows the geographic impact of Beini Cen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beini Cen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beini Cen more than expected).

Fields of papers citing papers by Beini Cen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beini Cen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beini Cen. The network helps show where Beini Cen may publish in the future.

Co-authorship network of co-authors of Beini Cen

This figure shows the co-authorship network connecting the top 25 collaborators of Beini Cen. A scholar is included among the top collaborators of Beini Cen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beini Cen. Beini Cen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wang, Shuai, Rui Wang, Xuyong Wei, et al.. (2023). SULT2B1-CS-DOCK2 axis regulates effector T-cell exhaustion in HCC microenvironment. Hepatology. 78(4). 1064–1078. 33 indexed citations
3.
Yang, Mengfan, Xuyong Wei, Qiang Wei, et al.. (2023). Stratified Analysis of Survival Benefit for ABO-incompatible Deceased-donor Liver Transplantation: Multicenter Propensity Score-matched Study. Journal of Clinical and Translational Hepatology. 0(0). 0–0. 2 indexed citations
4.
Qiu, Nasha, Zhen Zhang, Xuyong Wei, et al.. (2023). Peritoneal Gene Transfection of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand for Tumor Surveillance and Prophylaxis. Nano Letters. 23(17). 7859–7868. 5 indexed citations
5.
Yang, Mengfan, Di Lu, Xuyong Wei, et al.. (2022). Development of a Novel Prognostic Nomogram for High Model for End-Stage Liver Disease Score Recipients Following Deceased Donor Liver Transplantation. Frontiers in Medicine. 9. 772048–772048. 6 indexed citations
6.
Zhuo, Jianyong, Di Lu, Jianguo Wang, et al.. (2021). Molecular phenotypes reveal heterogeneous engraftments of patient-derived hepatocellular carcinoma xenografts. Chinese Journal of Cancer Research. 33(4). 470–479. 10 indexed citations
7.
Zhuo, Jianyong, Di Lu, Zuyuan Lin, et al.. (2021). The distinct responsiveness of cytokeratin 19-positive hepatocellular carcinoma to regorafenib. Cell Death and Disease. 12(12). 1084–1084. 26 indexed citations
8.
Zhang, Wenhui, Zhikun Liu, Junli Chen, et al.. (2021). A preoperative model for predicting microvascular invasion and assisting in prognostic stratification in liver transplantation for HCC regarding empirical criteria. Translational Oncology. 14(11). 101200–101200. 10 indexed citations
9.
Pan, Binhua, Modan Yang, Xuyong Wei, et al.. (2021). Interleukin-2 inducible T-cell kinase: a potential prognostic biomarker and tumor microenvironment remodeling indicator for hepatocellular carcinoma. Aging. 13(14). 18620–18644. 2 indexed citations
10.
11.
Zhuo, Jianyong, Di Lu, Zuyuan Lin, et al.. (2020). C C motif chemokine ligand 16 inhibits the progression of liver cirrhosis via inactivating hepatic stellate cells. Hepatobiliary & pancreatic diseases international. 19(5). 440–448. 13 indexed citations
12.
Zhan, Qifan, Sunbin Ling, Yinan Deng, et al.. (2020). Hangzhou criteria as downstaging criteria in hepatocellular carcinoma before liver transplantation: A multicenter study from China. Hepatobiliary & pancreatic diseases international. 19(4). 349–357. 18 indexed citations
13.
Shi, Linlin, Yuchen Wang, Qinchuan Wang, et al.. (2020). Transforming a toxic drug into an efficacious nanomedicine using a lipoprodrug strategy for the treatment of patient-derived melanoma xenografts. Journal of Controlled Release. 324. 289–302. 62 indexed citations
14.
Ling, Sunbin, Tingting Feng, Qifan Zhan, et al.. (2020). Sirolimus-based immunosuppression improves outcomes in liver transplantation recipients with hepatocellular carcinoma beyond the Hangzhou criteria. Annals of Translational Medicine. 8(4). 80–80. 11 indexed citations
15.
Zhang, Chenzhi, Kangchen Chen, Rongli Wei, et al.. (2020). The circFASN/miR-33a pathway participates in tacrolimus-induced dysregulation of hepatic triglyceride homeostasis. Signal Transduction and Targeted Therapy. 5(1). 23–23. 20 indexed citations
16.
Pan, Binhua, Modan Yang, Xuyong Wei, et al.. (2020). Interleukin-2 Inducible T-Cell Kinase: A Potential Prognostic Biomarker and Tumor Microenvironment Remodeling Indicator for Hepatocellular Carcinoma. SSRN Electronic Journal. 1 indexed citations
17.
Yang, Modan, Xinyu Yang, Jianyong Zhuo, et al.. (2020). Homocysteine: A novel prognostic biomarker in liver transplantation for alpha-fetoprotein- negative hepatocellular carcinoma. Cancer Biomarkers. 29(2). 197–206. 6 indexed citations
18.
Lu, Di, Fan Yang, Jianyong Zhuo, et al.. (2020). The Matching Status Between Donor and Recipient Hepatitis B Seroepidemiology Makes a Difference in Liver Transplantation for Hepatocellular Carcinoma. Clinical and Translational Gastroenterology. 11(5). e00168–e00168. 4 indexed citations
19.
Lu, Di, Fan Yang, Zuyuan Lin, et al.. (2019). A prognostic fingerprint in liver transplantation for hepatocellular carcinoma based on plasma metabolomics profiling. European Journal of Surgical Oncology. 45(12). 2347–2352. 17 indexed citations
20.
Shuai, Qi, Jianqin Wan, Beini Cen, et al.. (2019). Self-assembling poly(ethylene glycol)-block-polylactide-cabazitaxel conjugate nanoparticles for anticancer therapy with high efficacy and low in vivo toxicity. International Journal of Pharmaceutics. 574. 118879–118879. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Runzhou Zhuang Breakdown of academic impact, for papers by Jingyuan Wang Breakdown of academic impact, for papers by Man Shu Breakdown of academic impact, for papers by Xiuling Lv Breakdown of academic impact, for papers by Amin Li Breakdown of academic impact, for papers by Shuguang Ju Breakdown of academic impact, for papers by Gianmarco Villano Breakdown of academic impact, for papers by Changli Peng
Rankless by CCL
2026